IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FOCA', EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.790
AS - Asia 5.546
EU - Europa 4.611
SA - Sud America 1.077
AF - Africa 178
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 21.239
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.565
SG - Singapore 1.979
CN - Cina 1.587
IT - Italia 1.110
BR - Brasile 892
DE - Germania 695
UA - Ucraina 687
HK - Hong Kong 676
VN - Vietnam 418
PL - Polonia 390
FI - Finlandia 341
GB - Regno Unito 339
FR - Francia 275
RU - Federazione Russa 237
BD - Bangladesh 206
TR - Turchia 201
IE - Irlanda 157
IN - India 144
CA - Canada 113
NL - Olanda 93
MX - Messico 72
AR - Argentina 65
SE - Svezia 65
JP - Giappone 57
ZA - Sudafrica 45
BF - Burkina Faso 41
ES - Italia 41
AT - Austria 40
ID - Indonesia 40
IQ - Iraq 38
CZ - Repubblica Ceca 32
EC - Ecuador 24
SA - Arabia Saudita 24
PK - Pakistan 22
AU - Australia 20
CL - Cile 20
BE - Belgio 18
LT - Lituania 18
VE - Venezuela 18
CO - Colombia 17
JO - Giordania 17
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
NG - Nigeria 15
EU - Europa 14
IL - Israele 13
MA - Marocco 13
CH - Svizzera 12
EG - Egitto 12
PE - Perù 12
PY - Paraguay 12
JM - Giamaica 11
KE - Kenya 11
TN - Tunisia 11
AZ - Azerbaigian 10
PT - Portogallo 9
UY - Uruguay 9
CR - Costa Rica 7
KZ - Kazakistan 7
MY - Malesia 7
PH - Filippine 7
BO - Bolivia 6
GR - Grecia 6
IR - Iran 6
KR - Corea 6
LK - Sri Lanka 6
TH - Thailandia 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
NP - Nepal 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
BY - Bielorussia 4
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
HR - Croazia 4
KG - Kirghizistan 4
LV - Lettonia 4
MK - Macedonia 4
UG - Uganda 4
AM - Armenia 3
CG - Congo 3
DZ - Algeria 3
HU - Ungheria 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
SY - Repubblica araba siriana 3
AL - Albania 2
CM - Camerun 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 21.212
Salva come PNG Salva come JPEG
Città #
Singapore 1.038
Ashburn 931
Fairfield 842
Hong Kong 672
Woodbridge 618
Jacksonville 524
San Jose 505
Houston 420
Chandler 396
Warsaw 381
Seattle 364
Beijing 343
The Dalles 343
Wilmington 342
New York 326
Ann Arbor 319
Cambridge 299
Princeton 269
Helsinki 230
Los Angeles 223
Lauterbourg 169
Brescia 166
Nanjing 166
Istanbul 162
Munich 159
Dublin 154
Ho Chi Minh City 147
Dallas 134
Council Bluffs 110
Milan 95
Buffalo 86
Des Moines 81
Moscow 76
Shanghai 75
São Paulo 71
Hanoi 70
Chicago 66
Redondo Beach 65
Dearborn 62
San Francisco 62
Orem 59
Santa Clara 58
Nanchang 53
Tokyo 53
Tianjin 52
San Diego 51
Frankfurt am Main 49
Changsha 47
Turku 47
London 46
Jinan 45
Shenyang 45
Ouagadougou 40
Hebei 37
Chennai 36
Nuremberg 36
Rome 36
Toronto 36
Montreal 35
Lancaster 34
Phoenix 32
Boardman 31
Amsterdam 29
Hangzhou 29
Denver 28
Rio de Janeiro 28
Belo Horizonte 27
Brooklyn 27
Poplar 26
Zhengzhou 26
Jiaxing 25
Johannesburg 24
Atlanta 23
Boston 23
Brno 23
Düsseldorf 23
Haiphong 23
Mexico City 23
Stockholm 23
Manchester 22
Mumbai 21
Vienna 21
Bologna 20
Ningbo 20
Charlotte 19
Romola 19
Dhaka 18
Kunming 18
Paris 18
Salt Lake City 18
Taizhou 18
Washington 18
Brussels 17
Verona 17
Baghdad 16
Brasília 16
Curitiba 16
Dong Ket 16
Amman 15
Jakarta 15
Totale 13.327
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 478
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 271
Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm 249
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 242
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 240
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 233
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 227
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 221
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 220
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 206
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 204
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 202
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 200
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 199
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 197
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 191
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 190
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 187
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 183
Virological effectiveness and CD4+ T-cell increase over early andlate courses in HIV infected patients on antiretroviral therapy: focus on HCV andanchor class received 178
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 176
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 176
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 171
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 170
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 168
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? 166
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 166
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 164
UVA1 phototherapy as a treatment option for plaque psoriasis in HIV-positive patients 163
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 162
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 160
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 159
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 159
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 159
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 158
DTG prescribing patterns in PLWH ≥65 years: the impact of 2DR and weight gain 157
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 156
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study 154
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 153
Phenotypic and genotypic evaluation of slime production by conventional and molecular microbiological techniques 152
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 150
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 149
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 149
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 148
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 146
Elderly women with human immunodeficiency virus infection: is there an effect of the virus on neuropsychological prolife? 145
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort 145
Adverse events associated to HAART in Burkina Faso 143
High prevalence of radiological vertebral fractures in HIV-infected males 143
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir 143
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. 142
Perinatally HIV-Infected Youths After Transition from Pediatric to Adult Care, a Single-Center Experience from Northern Italy 141
Coming home to be cared. Emigration and antiretroviral treatment in the Nanoro health district, Burkina Faso. 140
Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV 139
Management of neurocysticercosis in Northern Italy: presentation of 11 cases and review of the literature on an emerging infection 138
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 138
Malaria and HIV in adults: When the parasite runs into the virus 138
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 136
Malaria prophylaxis. A comprehensive review 135
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 132
HIV/HBV and HIV/HCV co-infection in Burkina Faso, West Africa 131
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: An Italian randomized clinical trial 131
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 131
Qualitative and quantitative analysis of mortality and morbidity at the health facilities in the rural district of Nanoro, Burkina Faso 129
Drug-specific risk of adverse events onset related to HAART in a resource-limited setting from 2001 to 2009: the experience of 3 medical centers in Burkina Faso 129
Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of Hepatocellular carcinoma (HCC): a single-centre study 128
Disengagement and reengagement of HIV continuum of care in a single center cohort in northern Italy 126
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover 125
The use of ultrasonography, transient elestography, APRI and FIB-4 to measure liver steatosis and fibrosis in HIV-positive patients not co-infected with hepatitis viruses with hypertransaminasemia of unknown origin on HAART 123
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 123
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 122
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? 122
International migrations and HIV care in the rural District of Nanoro, Burkina Faso 122
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 122
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 121
Coming home to be cared. Emigration and antiretroviral treatment in the Nanoro health District, Burkina Faso 121
Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. 120
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: Results of a 3-year cohort study 119
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 118
The good, the bad and the ugly: Determinants of antiretroviral-associated toxicities 118
Amebiasi e infezione da amebe a vita libera 117
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience 117
Infezioni intestinali da protozoi e tricomoniasi 115
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 114
An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene: A case report 114
Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated Infection 113
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry 113
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 112
Pregnancy related immune-deficit in HIV-infected pregnant women in resource-limited countries. Implications for HAART initiation 110
Unboosted Atazanavir for Treatment ofHIV Infection: Rationale and Recommendations for Use 110
User fees and compliance to HAART in Ouagadougou, Burkina Faso 109
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort 109
A 2021 update on syphilis: Taking stock from pathogenesis to vaccines 109
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 108
Monitoring the toxicity related to HAART from 2001 to 2009 in Burkina Faso: clinical adverse events vs. laboratori adverse events: prevalence, grading and outcome 107
SARS-CoV-2 invades the West. How to face a COVID-19 epidemic in Lombardy, Northern Italy? 107
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic 105
Chronic Hepatitis C Cascade of Care in Prisoners—Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy 104
Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV 104
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 103
Totale 15.288
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/20221.208 85 156 25 77 42 71 74 89 67 134 103 285
2022/20231.187 157 19 23 82 112 293 5 124 218 10 77 67
2023/20241.449 91 27 124 107 67 272 64 62 317 25 54 239
2024/20253.566 41 36 41 447 322 330 292 157 426 346 677 451
2025/20267.593 697 856 512 1.133 937 552 1.054 278 450 606 360 158
Totale 21.676